255 related articles for article (PubMed ID: 26439800)
1. Sustained Epigenetic Drug Delivery Depletes Cholesterol-Sphingomyelin Rafts from Resistant Breast Cancer Cells, Influencing Biophysical Characteristics of Membrane Lipids.
Raghavan V; Vijayaraghavalu S; Peetla C; Yamada M; Morisada M; Labhasetwar V
Langmuir; 2015 Oct; 31(42):11564-73. PubMed ID: 26439800
[TBL] [Abstract][Full Text] [Related]
2. Epigenetic modulation of the biophysical properties of drug-resistant cell lipids to restore drug transport and endocytic functions.
Vijayaraghavalu S; Peetla C; Lu S; Labhasetwar V
Mol Pharm; 2012 Sep; 9(9):2730-42. PubMed ID: 22817326
[TBL] [Abstract][Full Text] [Related]
3. Drug resistance in breast cancer cells: biophysical characterization of and doxorubicin interactions with membrane lipids.
Peetla C; Bhave R; Vijayaraghavalu S; Stine A; Kooijman E; Labhasetwar V
Mol Pharm; 2010 Dec; 7(6):2334-48. PubMed ID: 20958074
[TBL] [Abstract][Full Text] [Related]
4. A combined fluorescence spectroscopy, confocal and 2-photon microscopy approach to re-evaluate the properties of sphingolipid domains.
Pinto SN; Fernandes F; Fedorov A; Futerman AH; Silva LC; Prieto M
Biochim Biophys Acta; 2013 Sep; 1828(9):2099-110. PubMed ID: 23702462
[TBL] [Abstract][Full Text] [Related]
5. Properties of Langmuir and solid supported lipid films with sphingomyelin.
Jurak M; Golabek M; Holysz L; Chibowski E
Adv Colloid Interface Sci; 2015 Aug; 222():385-97. PubMed ID: 24725646
[TBL] [Abstract][Full Text] [Related]
6. Chemical-physical changes in cell membrane microdomains of breast cancer cells after omega-3 PUFA incorporation.
Corsetto PA; Cremona A; Montorfano G; Jovenitti IE; Orsini F; Arosio P; Rizzo AM
Cell Biochem Biophys; 2012 Sep; 64(1):45-59. PubMed ID: 22622660
[TBL] [Abstract][Full Text] [Related]
7. Lipid rafts reconstituted in model membranes.
Dietrich C; Bagatolli LA; Volovyk ZN; Thompson NL; Levi M; Jacobson K; Gratton E
Biophys J; 2001 Mar; 80(3):1417-28. PubMed ID: 11222302
[TBL] [Abstract][Full Text] [Related]
8. Neutron reflection study of the interaction of the eukaryotic pore-forming actinoporin equinatoxin II with lipid membranes reveals intermediate states in pore formation.
Wacklin HP; Bremec BB; Moulin M; Rojko N; Haertlein M; Forsyth T; Anderluh G; Norton RS
Biochim Biophys Acta; 2016 Apr; 1858(4):640-52. PubMed ID: 26706098
[TBL] [Abstract][Full Text] [Related]
9. Nanogel-mediated delivery of a cocktail of epigenetic drugs plus doxorubicin overcomes drug resistance in breast cancer cells.
Vijayaraghavalu S; Labhasetwar V
Drug Deliv Transl Res; 2018 Oct; 8(5):1289-1299. PubMed ID: 29947019
[TBL] [Abstract][Full Text] [Related]
10. A solid-state NMR study of phospholipid-cholesterol interactions: sphingomyelin-cholesterol binary systems.
Guo W; Kurze V; Huber T; Afdhal NH; Beyer K; Hamilton JA
Biophys J; 2002 Sep; 83(3):1465-78. PubMed ID: 12202372
[TBL] [Abstract][Full Text] [Related]
11. Cyclosporin A distribution in cholesterol-sphingomyelin artificial membranes modeled as Langmuir monolayers.
Wnętrzak A; Makyła-Juzak K; Chachaj-Brekiesz A; Lipiec E; Romeu NV; Dynarowicz-Latka P
Colloids Surf B Biointerfaces; 2018 Jun; 166():286-294. PubMed ID: 29604571
[TBL] [Abstract][Full Text] [Related]
12. A biophysical approach to daunorubicin interaction with model membranes: relevance for the drug's biological activity.
Alves AC; Ribeiro D; Horta M; Lima JLFC; Nunes C; Reis S
J R Soc Interface; 2017 Aug; 14(133):. PubMed ID: 28855387
[TBL] [Abstract][Full Text] [Related]
13. Edelfosine disturbs the sphingomyelin-cholesterol model membrane system in a cholesterol-dependent way - the Langmuir monolayer study.
Hąc-Wydro K; Dynarowicz-Łątka P; Wydro P; Bąk K
Colloids Surf B Biointerfaces; 2011 Dec; 88(2):635-40. PubMed ID: 21862295
[TBL] [Abstract][Full Text] [Related]
14. Cholesterol and Sphingomyelin-Containing Model Condensed Lipid Monolayers: Heterogeneities Involving Ordered Microdomains Assessed by Two Cholesterol Derivatives.
Lecompte MF; Gaibelet G; Lebrun C; Tercé F; Collet X; Orlowski S
Langmuir; 2015 Nov; 31(43):11921-31. PubMed ID: 26466013
[TBL] [Abstract][Full Text] [Related]
15. Electron spin resonance characterization of liquid ordered phase of detergent-resistant membranes from RBL-2H3 cells.
Ge M; Field KA; Aneja R; Holowka D; Baird B; Freed JH
Biophys J; 1999 Aug; 77(2):925-33. PubMed ID: 10423437
[TBL] [Abstract][Full Text] [Related]
16. Ceramide-domain formation and collapse in lipid rafts: membrane reorganization by an apoptotic lipid.
Silva LC; de Almeida RF; Castro BM; Fedorov A; Prieto M
Biophys J; 2007 Jan; 92(2):502-16. PubMed ID: 17056734
[TBL] [Abstract][Full Text] [Related]
17. Aspirin inhibits formation of cholesterol rafts in fluid lipid membranes.
Alsop RJ; Toppozini L; Marquardt D; Kučerka N; Harroun TA; Rheinstädter MC
Biochim Biophys Acta; 2015 Mar; 1848(3):805-12. PubMed ID: 25475646
[TBL] [Abstract][Full Text] [Related]
18. Structure, composition, and peptide binding properties of detergent soluble bilayers and detergent resistant rafts.
Gandhavadi M; Allende D; Vidal A; Simon SA; McIntosh TJ
Biophys J; 2002 Mar; 82(3):1469-82. PubMed ID: 11867462
[TBL] [Abstract][Full Text] [Related]
19. Role of cholesterol in the formation and nature of lipid rafts in planar and spherical model membranes.
Crane JM; Tamm LK
Biophys J; 2004 May; 86(5):2965-79. PubMed ID: 15111412
[TBL] [Abstract][Full Text] [Related]
20. Pathological levels of glucosylceramide change the biophysical properties of artificial and cell membranes.
Varela AR; Ventura AE; Carreira AC; Fedorov A; Futerman AH; Prieto M; Silva LC
Phys Chem Chem Phys; 2016 Dec; 19(1):340-346. PubMed ID: 27905603
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
